Growth & Later Stage Companies
Our experience at combining emerging growth with later stage companies provides our portfolio companies with a significant competitive advantage. Origin has become synonymous with innovation and growth, largely because our position in the market provides us with first-access to the latest scientific and medical advances.
We understand new ideas and early stage companies. Further, what it takes for them to grow and how to integrate them with larger assets or companies without compromising their innovation and leadership.
Many of our principals have been leading advisors to the technology and life science communities since the formation of Research Triangle and other major academic-science corridors. We combine scientific and medical advantages with practical business know-how accumulated over years of
experience advising academic centers, research institutes, emerging growth and later stage companies.
We use this experience to assist our portfolio companies through each phase of their life cycle, from initial planning and organization, to equity and debt financing and operational issues, through exit—whether initial public offering, merger, or sale. Because of our comprehensive
understanding of how companies are started, financed and later exited, we have become important advisors not only to early-stage companies, but also larger operating companies.